Atherosclerosis Obliterans

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Atherosclerosis Obliterans trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT05854615

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

The goal of this observational, practice-based feasibility study is to observe the efficacy and safety of intramuscular administration of Stempeucel® in Malaysi…

Malaysia3 participantsStarted 2024-01-01

Treatment: Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells

All recent trials (18 shown)

By InvitationNot Applicable

NCT07023965

Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)

The goal of this observational study is to learn about the long-term effects of Donaperminogene Seltoplasmid Injection (NL003) in participants who have been rec…

China542 participantsStarted 2025-06-30

Treatment: NL003, Placebo

CompletedPhase 4

NCT00823849

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

1. To evaluate the efficacy of Cilostazol and Probucol alone and in combination on atherosclerosis related biomarker 2. To evaluate the safety of Cilostazol and…

China200 participantsStarted 2008-10

Treatment: Cilostazol, Probucol

Atherosclerosis Obliterans

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

All recent trials (18 shown)

Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

All recent trials (18 shown)

Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

Combined Treatment for Non-Healing Wounds in Chronic Lower Extremity Arterial Disease: a Comparative Study

Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)

Lesion Preparation in Femoropopliteal Artery Occlusion Disease

Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents

Autologous Fat Grafting in the Treatment of Critical Limb Ischaemia

Comparison of 3 Ultrasonic Techniques for Measuring the Systolic Pressure Index

Soundbite Crossing System Peripheral First in Man

HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F)

A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Pa…

Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia

Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia

Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia

Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia

Viennese Registry on Patients With Chronic Critical Limb Ischemia

TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation